AMARIN CORP PLC\UK Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
AMARIN CORP PLC\UK (AMRN) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of $530.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-27.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2014-02-27
- AMARIN CORP PLC\UK effective income tax rate reconciliation, other reconciling items, amount for fiscal 2013 was $530.00K, a 239.74% increase from fiscal 2012.
- AMARIN CORP PLC\UK effective income tax rate reconciliation, other reconciling items, amount for fiscal 2012 was $156.00K, a 36.07% decline from fiscal 2011.
- AMARIN CORP PLC\UK effective income tax rate reconciliation, other reconciling items, amount for fiscal 2011 was $244.00K, a 30.68% decline from fiscal 2010.
- AMARIN CORP PLC\UK effective income tax rate reconciliation, other reconciling items, amount for fiscal 2010 was $352.00K, a 2.49% decline from fiscal 2009.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month |
|---|---|
| 2013-12-31 | $530.00K 10-K · filed 2014-02-27 |
| 2012-12-31 | $156.00K 10-K · filed 2014-02-27 |
| 2011-12-31 | $244.00K 10-K · filed 2014-02-27 |
| 2010-12-31 | $352.00K 10-K · filed 2013-02-28 |
| 2009-12-31 | $361.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |